Connection

NORM LEHMAN to Antineoplastic Agents

This is a "connection" page, showing publications NORM LEHMAN has written about Antineoplastic Agents.
Connection Strength

0.677
  1. The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells. J Neurooncol. 2018 May; 137(3):481-492.
    View in: PubMed
    Score: 0.302
  2. Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib. J Neuropathol Exp Neurol. 2015 Oct; 74(10):960-9.
    View in: PubMed
    Score: 0.256
  3. Future potential of thymidylate synthase inhibitors in cancer therapy. Expert Opin Investig Drugs. 2002 Dec; 11(12):1775-87.
    View in: PubMed
    Score: 0.105
  4. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells. Cancer Res. 1993 Dec 01; 53(23):5697-706.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.